Log in
Enquire now
User profile

Dmitry Suzko

Bachelor in medicine Qualified sales
Joined February 2022
512
Contributions
ContributionsActivity
Gyo SagaraGyo Sagara was edited byDmitry Suzko profile picture
Dmitry Suzko
June 15, 2022 10:29 pm
Infobox
CEO of
0
Current Employer
0
Location
0
Jean-Claude DubacherJean-Claude Dubacher was edited byDmitry Suzko profile picture
Dmitry Suzko
June 15, 2022 10:28 pm
Infobox
CEO of
0
Current Employer
0
Educated at
0
0
Founder of
0
Location
0
Ajay K SinghAjay K Singh was edited byDmitry Suzko profile picture
Dmitry Suzko
June 15, 2022 10:26 pm
Infobox
CEO of
0
Current Employer
0
Educated at
0
0
Founder of
0
Location
0
James C. GaleJames C. Gale was edited byDmitry Suzko profile picture
Dmitry Suzko
June 15, 2022 10:24 pm
Infobox
Educated at
0
Founder of
0
Location
0
Gaurav MehrotraGaurav Mehrotra was edited byDmitry Suzko profile picture
Dmitry Suzko
June 15, 2022 10:22 pm
Infobox
CFO of
0
Educated at
0
0
Location
0
‌
Venkat Krishnan
was edited byDmitry Suzko profile picture
Dmitry Suzko
June 15, 2022 10:20 pm
Infobox
CEO of
0
Educated at
0
Founder of
0
Location
0
Bryan WalserBryan Walser was edited byDmitry Suzko profile picture
Dmitry Suzko
June 15, 2022 10:17 pm
Infobox
CEO of
0
Educated at
0
0
0
0
0
Founder of
Aimmune Therapeutics
Aimmune Therapeutics
0
Bruce A. PeacockBruce A. Peacock was edited byDmitry Suzko profile picture
Dmitry Suzko
June 15, 2022 10:12 pm
Infobox
Founder of
Interius BioTherapeutics
Interius BioTherapeutics
0
‌
Interius BioTherapeutics Series A May 18, 2021
was edited byDmitry Suzko profile picture
Dmitry Suzko
June 3, 2022 11:22 pm
Infobox
Announcement URL
https://www.crunchbase.com/funding_round/interius-biotherapeutics-series-a--c3ff6ea7
Funded company
Interius BioTherapeutics
Interius BioTherapeutics
Funding round date
May 18, 2021
Funding round amount (USD)
76,000,000
Funding type
Series A
Series A
Investment
Cormorant Asset Management
Cormorant Asset Management
‌
Fairmount Funds Management
‌
Interius BioTherapeutics Series A May 18, 2021
was created byDmitry Suzko profile picture
Dmitry Suzko
"Created via: Web app"
June 3, 2022 11:20 pm
‌

Interius BioTherapeutics Series A May 18, 2021

‌
Interius BioTherapeutics Venture Round Mar 13, 2020
was edited byDmitry Suzko profile picture
Dmitry Suzko
June 3, 2022 11:19 pm
Infobox
Announcement URL
https://www.crunchbase.com/funding_round/interius-biotherapeutics-series-unknown--f005af9c
Funded company
Interius BioTherapeutics
Interius BioTherapeutics
Funding round date
March 13, 2020
Funding round amount (USD)
5,500,000
Funding type
‌
Venture round
Investment
Agent Capital
Agent Capital
‌
Geeta Vemuri
Bruce A. Peacock
Bruce A. Peacock
‌
Interius BioTherapeutics Venture Round Mar 13, 2020
was created byDmitry Suzko profile picture
Dmitry Suzko
"Created via: Web app"
June 3, 2022 11:17 pm
‌

Interius BioTherapeutics Venture Round Mar 13, 2020

Bruce A. PeacockBruce A. Peacock was edited byDmitry Suzko profile picture
Dmitry Suzko
June 3, 2022 11:16 pm
Topic thumbnail

Bruce A. Peacock

Infobox
LinkedIn URL
https://www.linkedin.com/in/bruce-peacock-3280777/
Location
Baltimore
Baltimore
Occupation
Investor
Investor
‌
Venture Partner
Interius BioTherapeuticsInterius BioTherapeutics was edited byDmitry Suzko profile picture
Dmitry Suzko
June 3, 2022 11:15 pm
Topic thumbnail

Interius BioTherapeutics

Novel methods for in vivo cell-specific gene delivery

Infobox
Legal name
Interius BioTherapeutics, Inc.
Company Operating Status
Active
Competitors
Amicus Therapeutics
Amicus Therapeutics
TARIS Biomedical
TARIS Biomedical
Crunchbase
https://www.crunchbase.com/organization/interius-biotherapeutics
Email address
info@interiusbio.com0
Founded date
2019
Founder
Bruce A. Peacock
Bruce A. Peacock
Full address
3401 Grays Ferry Avenue Building 200, Suite 300 Philadelphia, PA 191460
Industry
Biopharmaceutical
Biopharmaceutical
Therapeutics
Therapeutics
LinkedIn URL
https://www.linkedin.com/company/interius-biotherapeutics/about/
Location
Philadelphia
Philadelphia
Number of Employees (ranges)
20 – 490
Phone number
215.608.9333
610-639-4644
Aimmune TherapeuticsAimmune Therapeutics was edited byDmitry Suzko profile picture
Dmitry Suzko
June 3, 2022 11:08 pm
Infobox
Crunchbase
https://www.crunchbase.com/organization/allergen-research-corporation
‌
Aimmune Therapeutics Series B Mar 12, 2015
was edited byDmitry Suzko profile picture
Dmitry Suzko
June 3, 2022 11:07 pm
Infobox
Announcement URL
https://www.crunchbase.com/funding_round/allergen-research-corporation-series-b--5ccb2e35
Funded company
Aimmune Therapeutics
Aimmune Therapeutics
Funding round date
March 12, 2015
Funding round amount (USD)
80,000,000
Funding type
Series B
Series B
Investment
Foresite Capital
Foresite Capital
0
Longitude Capital
Longitude Capital
Patrick Enright
Patrick Enright
‌
Aimmune Therapeutics Series B Mar 12, 2015
was created byDmitry Suzko profile picture
Dmitry Suzko
"Created via: Web app"
June 3, 2022 11:05 pm
‌

Aimmune Therapeutics Series B Mar 12, 2015

Bryan WalserBryan Walser was edited byDmitry Suzko profile picture
Dmitry Suzko
June 3, 2022 11:04 pm
Topic thumbnail

Bryan Walser

Infobox
Founder of
Aimmune Therapeutics
Aimmune Therapeutics
Occupation
Investor
Investor
Aimmune TherapeuticsAimmune Therapeutics was edited byDmitry Suzko profile picture
Dmitry Suzko
June 3, 2022 11:01 pm
Topic thumbnail

Aimmune Therapeutics

Food allergy therapies

Infobox
Website URL
http://aimmune.com
Acquirer
Nestle Health Science
Nestle Health Science
Legal name
Aimmune Therapeutics, Inc.
Company Operating Status
Active
Competitors
Aclaris Therapeutics
Aclaris Therapeutics
Interius BioTherapeutics
Interius BioTherapeutics
Email address
corporatedevelopment@aimmune.com0
hr@aimmune.com
media@aimmune.com
Founded date
2011
Industry
Healthcare
Healthcare
Therapeutics
Therapeutics
Number of Employees (ranges)
250 – 499
Phone number
(650)614-5220
Exchange
Nasdaq
Nasdaq
Stock symbol
AIMT
‌
Alpine Immune Sciences Seed Round Jun 23, 2015
was edited byDmitry Suzko profile picture
Dmitry Suzko
June 3, 2022 10:54 pm
Infobox
Announcement URL
https://www.crunchbase.com/funding_round/alpine-immune-sciences-seed--b3c230a4
Funded company
Alpine Immune Sciences
Alpine Immune Sciences
Funding round date
January 23, 2015
Funding round amount (USD)
1,300,000
Funding type
Seed
Seed